Investigational Blood Biomarker Panel May Improve Detection of Pancreatic Cancer
PHILADELPHIA – A four-biomarker blood panel of aminopeptidase N (ANPEP), polymeric immunoglobulin receptor (PIGR), CA19-9, and thrombospondin-2 (THBS2) enhanced...
Search/Filter
Loading...
Elizabeth M. Jaffee, MD, FAACR, and Antoni Ribas, MD, PhD, FAACR, Named New Editors-in-Chief of the AACR Journal Cancer Immunology Research
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Elizabeth M. Jaffee, MD, FAACR, and Antoni Ribas,...
ctDNA Levels After Neoadjuvant Therapy May Predict Breast Cancer Recurrence Better Than Pathologic Complete Response
ctDNA status after neoadjuvant therapy may also inform adjuvant therapy PHILADELPHIA – The presence of circulating tumor DNA (ctDNA)...
Ross Levine, MD, Selected as Editor-in-Chief of the AACR Journal Blood Cancer Discovery
PHILADELPHIA – The American Association for Cancer Research (AACR) today announced the appointment of Ross Levine, MD, as editor-in-chief...
AACR Expresses Support for FDA’s Proposed Rule to Decrease Nicotine Content in Certain Combusted Tobacco Products
PHILADELPHIA – The American Association for Cancer Research (AACR) today released a policy statement in support of a rule proposed...
A Combination Treatment May Help Cut Lifelong Ibrutinib for Chronic Lymphocytic Leukemia
PHILADELPHIA – Adding the investigational antibody ianalumab (VAY736) to ibrutinib (Imbruvica) allowed some patients with chronic lymphocytic leukemia (CLL)...
New Combination Therapy Shows Promise for Aggressive Lymphoma Resistant to Immunotherapy
Epigenetic therapy boosted immunotherapy response in refractory natural killer/T-cell lymphoma by turning cold tumors hot PHILADELPHIA – Combining an...
Medicaid Expansion Linked to Improved Long-term Survival in Cancer Patients
Certain cancer patients in U.S. states that expanded Medicaid experienced increased survival, especially in rural and high-poverty regions PHILADELPHIA...
A Polygenic Risk Score May Predict Future Breast Cancer in Patients With Early-stage Diagnoses
Patients diagnosed with abnormal breast cells were more likely to receive a later diagnosis of breast cancer if their...
Real-world Data Shows Teclistamab Can Benefit Many Multiple Myeloma Patients Who Would Have Been Ineligible for Pivotal Trial
Retrospective study revealed efficacy of the bispecific T-cell engager in patients with high-risk, heavily pretreated multiple myeloma, including after...